<SEC-DOCUMENT>0001104659-15-014023-index.html : 20150226 <SEC-HEADER>0001104659-15-014023.hdr.sgml : 20150226 <ACCEPTANCE-DATETIME>20150226060548 ACCESSION NUMBER: 0001104659-15-014023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20150225 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150226 DATE AS OF CHANGE: 20150226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 15649988 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a15-5217_38k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a15-5217_38k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>a15-5217_3ex1d1.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: a15-5217_3ex1d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>a15-5217_3ex5d1.htm <DESCRIPTION>EX-5.1 <TEXT> Document 3 - file: a15-5217_3ex5d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>a15-5217_3ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: a15-5217_3ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g52173mmi001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g52173mmi001.jpg
</DOCUMENT> </SEC-DOCUMENT>